Abstract:Spinal cord injury (SCI) is a cause of profound and irreversible damage, with no effective therapy to promote functional recovery. Photobiomodulation (PBM) may provide a viable therapeutic approach using red or near‐infrared light to promote recovery after SCI by mitigating neuroinflammation and preventing neuronal apoptosis. Our current study aimed to optimize PBM dose regimens and develop and validate the efficacy of an invasive PBM delivery paradigm for SCI. Dose optimization studies were performed using a serum withdrawal model of injury in cultures of primary adult rat dorsal root ganglion neurons (DRGN). Implantable and transcutaneous PBM delivery protocols were developed and validated using cadaveric modeling. The efficacy of PBM in promoting recovery after SCI in vivo was studied in a dorsal column crush injury model of SCI in adult rats. Optimal neuroprotection in vitro was achieved between 4 and 22 mW/cm2. 11 mW/cm2 for 1 min per day (0.66 J/cm2) increased cell viability by 45% over 5 days (p <0.0001), increasing neurite outgrowth by 25% (p <0.01). A method for invasive application of PBM was developed using a diffusion‐tipped optogenetics fiber optic. Delivery methods for PBM were developed and validated for both invasive (iPBM) and noninvasive (transcutaneous) (tcPBM) application. iPBM and tcPBM (24 mW/cm2 at spinal cord, 1 min per day (1.44 J/cm2) up to 7 days) increased activation of regeneration‐associated protein at 3 days after SCI, increasing GAP43+ axons in DRGN from 18.0% (control) to 41.4% ± 10.5 (iPBM) and 45.8% ± 3.4 (tcPBM) (p <0.05). This corresponded to significant improvements at 6 weeks post‐injury in functional locomotor and sensory function recovery (p <0.01), axonal regeneration (p <0.01), and reduced lesion size (p <0.01). Our results demonstrated that PBM achieved a significant therapeutic benefit after SCI, either using iPBM or tcPBM application and can potentially be developed for clinical use in SCI patients.

Tailoring photobiomodulation to enhance tissue regeneration

The role of photobiomodulation in accelerating bone repair

Photobiomodulation on Muscle Regeneration

Photobiomodulation in Ophthalmology: A Comprehensive Review of Bench-to-Bedside Research and Clinical Integration

Photobiomodulation (PBM) promotes angiogenesis in-vitro and in chick embryo chorioallantoic membrane model

Photobiomodulation promotes angiogenesis in wound healing through stimulating the nuclear translocation of VEGFR2 and STAT3

Photobiomodulation CME Part I: Overview and Mechanism of Action

Photobiomodulation use in ophthalmology - an overview of translational research from bench to bedside

Wavelength-dependent photobiomodulation (PBM) for proliferation and angiogenesis of melanoma tumor in vitro and in vivo

Considerations for the Use of Photobiomodulation in the Treatment of Retinal Diseases

Green Light‐Based Photobiomodulation with an Implantable and Biodegradable Fiber for Bone Regeneration (small Methods 7/2020)

Cellular Rehabilitation of Photobiomodulation

Photobiomodulation on Tumor Cells in Vitro and Tumor Tissue in Vivo

Photobiomodulation – the Chinese Approaches and Advances in Clinical Application/photobiomodulation – Der Chinesische Ansatz Und Fortschritte in Der Klinischen Anwendung

Photobiomodulation on Senescence

Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics

Photosensitive Materials and Potential of Photocurrent Mediated Tissue Regeneration

Photobiomodulation CME Part II: Clinical Applications in Dermatology

Tailoring Physicochemical Properties of Photothermal Hydrogels Toward Intrinsically Regenerative Therapies

Photobiomodulation Facilitates Rat Cutaneous Wound Healing by Promoting Epidermal Stem Cells and Hair Follicle Stem Cells Proliferation

Implantable and transcutaneous photobiomodulation promote neuroregeneration and recovery of lost function after spinal cord injury